Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79B

Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79B

US Patent 12325728 · Granted Jun 10, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor and methods of use thereof2025
Methods and compositions for transducing lymphocytes and regulating the activity2025
Methods and compositions for transducing lymphocytes and regulating the activity2025
Methods and compositions for transducing lymphocytes and regulating the activity2025
Methods and compositions for transducing lymphocytes and regulating the activity2025
Methods and compositions for transducing lymphocytes and regulating the activity2025
Chimeric antigen receptors against AXL or ROR2 and methods of use thereof2025
Chimeric antigen receptors against AXL or ROR2 and methods of use thereof2025
Chimeric antigen receptor and methods of use thereof2024
Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial v2024
Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyalu2023
Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyalu2023